PCSK9 Protein, Cynomolgus, Recombinant (His) NEW
| Price | $418 |
| Package | 100μg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-08-27 |
Product Details
| Product Name: PCSK9 Protein, Cynomolgus, Recombinant (His) | Supply Ability: 10g |
| Release date: 2025/08/27 |
Product Introduction
Bioactivity
| Name | PCSK9 Protein, Cynomolgus, Recombinant (His) |
| Description | Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme encoded by the PCSK9 gene in humans on chromosome 1.The first two PCSK9 inhibitors, alirocumab and evolocumab, were approved as once every two week injections, by the U.S. Food and Drug Administration in 2015 for lowering LDL-particle concentrations when statins and other drugs were not sufficiently effective or poorly tolerated. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | PCSK-9 | PCSK 9 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $377.00/100μg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 | |
| $1520.00/500μg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-08-27 | |
| $0.00/1kg |
VIP3Y
|
Sichuan HongRi Pharma-Tech Co.,Ltd
|
2023-09-25 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY

United States